5am-Venture-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
31
Total Value
264407625
Accession Number
0001085146-25-003293
Form Type
13F-HR
Manager Name
5am-Venture-Management
Data Enrichment
100% identified
31 identified0 unidentified

Holdings

31 positions • $264.4M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Vor Biopharma Inc.
Shares:6.4M
Value:$4.6M
% of Portfolio:1.7% ($4.6M/$264.4M)
Surrozen, Inc./DE
Shares:310.0K
Value:$3.6M
% of Portfolio:1.4% ($3.6M/$264.4M)
Protara Therapeutics, Inc.
Shares:800.0K
Value:$3.4M
% of Portfolio:1.3% ($3.4M/$264.4M)
scPharmaceuticals Inc.
Shares:1.2M
Value:$3.2M
% of Portfolio:1.2% ($3.2M/$264.4M)
Rallybio Corp
Shares:3.6M
Value:$2.4M
% of Portfolio:0.9% ($2.4M/$264.4M)
Adverum Biotechnologies, Inc.
Shares:541.7K
Value:$2.4M
% of Portfolio:0.9% ($2.4M/$264.4M)
Silence Therapeutics plc
Shares:476.2K
Value:$1.3M
% of Portfolio:0.5% ($1.3M/$264.4M)
Alector, Inc.
Shares:995.8K
Value:$1.2M
% of Portfolio:0.5% ($1.2M/$264.4M)
Cidara Therapeutics, Inc.
Shares:56.7K
Value:$1.2M
% of Portfolio:0.5% ($1.2M/$264.4M)
Zentalis Pharmaceuticals, Inc.
Shares:490.0K
Value:$779.1K
% of Portfolio:0.3% ($779.1K/$264.4M)
Mersana Therapeutics, Inc.
Shares:1.3M
Value:$449.2K
% of Portfolio:0.2% ($449.2K/$264.4M)